Skip to content

Telaprevir works well for people with HIV/HCV co-infection

Mark Sulkowski of Johns Hopkins University. Photo by Liz Highleyman / aidsmap.com

Non-invasive tests can predict which HIV-positive women have increased risk of liver disease

9% prevalence of hepatitis C co-infection among UK HIV patients

Warning issued to Fuzeon, Pegasys, Viraferon Peg and Intron A users

Sex and drug use driving HCV epidemic among HIV-positive gay men in Australia; other study shows small epidemic in US

Good outcomes among HIV-positive patients having a liver transplant due to cancer

Fatty liver disease associated with cardiovascular risk in patients with HIV

European recommendations issued on acute hepatitis C infection in patients with HIV

Nucleoside/nucleotide analogue therapy slows liver disease in HIV/HBV-co-infected patients